Clinical variants of Alzheimer disease;Variabilidad y variantes de la enfermedad de Alzheimer

Revista Medica de Chile

Volumn 133, Issue 4, 2005, Pages 477-482

  Donoso S, Archibaldo ^a   Behrens P, María Isabel ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Early onset alzheimer disease; Focal onset alzheimer disease; Late onset alzheimer disease; Psychosis

Indexed keywords

ALZHEIMER DISEASE; CLASSIFICATION; HUMAN; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; HUMANS;

EID: 31144454330     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. MAYEUX R, STERN Y, SPANTON S. Heterogeneity in dementia of the Alzheimer type. Neurology 1985; 35: 453-60.
2. GALTON CJ, PATTERSON K, XUEREB JH, HODGEN IR. Atypical and typical presentation of Alzheimer's disease, a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000; 123: 484-98.
3. DONOSO A, QUIROZ M, YULIS J. Demencia de tipo Alzheimer: experiencia clínica en 71 casos. Rev Méd Chile 1990; 118: 139-45.
4. LIEBSON E, ALBERT M. Cognitive changes in dementia of the Alzheimer type. En: Calne DB ed: Neurodegenerative disorders. Philadelphia, WB Saunders Co, 1994.
5. LARSON E, SHADIEN M-F, WANG L, MCCORMICK W, BOWEN J, TERI L ET AL. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004; 140: 501-9.
6. BROOKMEYER R, CORRADA MM, CURRIERO F, KAWAS C. Survival following a diagnosis of Alzheimer's disease. Arch Neurol 2002; 59: 1764-7.
7. HOLMES C. Genotype and phenotype in Alzheimer's disease. J Psychiatry 2002; 180: 131-4.
8. SELKOE DJ. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Int Med 2004; 140: 627-38.
9. VAN DIJK E, PRINS ND, VERMEER S, HOFMAN A, VAN DUIJN C, KOUDSTAAL P ET AL. Plasma amyloid beta, apolipoprotein E, lacunar infarcts and white matter lesions. Ann Neurol 2004; 55: 570-5.
10. KENNEDY AM, ROSSOR MN, HODGES JR. Familial and sporadic Alzheimer's disease, en JR Hodges ed: Early-onset dementia: a multidisciplinary approach. Oxford University Press, Oxford 2001.
11. MORETTI P, LIEBERMAN AP, WILDE EA, GIORDANI BI, KLUIN KJ, KOEPPRE RA ET AL. Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis. Neurology 2004; 62: 1865-9.
12. JANSSEN JC, BECK JA, CAMPBELL A, DICKINSON NC, FOX RJ, HARNEY RJ ET AL. Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology 2003; 60: 235-9.
13. PASTOR P, ROE CM, VILLEGAS A, BEDOYA G, CHAKRAVERTY S, GARCÍA G ET AL. Apolipoprotein E epsilon 4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol 2003; 54: 163-9.
14. PETERSEN R, SMITH GE, WARING SC, IVNIK RJ, TANGALOS EG, KOKMEN E. Mild cognitive impairment, clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
15. SELTZAR B, SHERWIN Y. A comparison of clinical features in early and late onset primary degenerative dementia. One entity or two. Arch Neurol 1983; 40: 143-6.
16. CUMMINGS JL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology 1997; 48 (supl 6): S10-16.
17. STARKSTEIN S, PETRACCA G, CHEMERINSKI E, KREMER J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158: 872-7.
18. ASSAL F, CUMMINGS JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 2002; 15: 445-50.
19. BOLAND RJ. Depression in Alzheimer's disease and other dementias. Curr Psychiat Report 2000; 2: 427-33.
20. ALEXOPOULOS GS, MEYER BS, YOUNG PC, MATTIS S, KAKUME T. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiat 1993; 150: 1693-9.
21. COOK SE, MIYAHARA S, BACANU SA, PÉREZ-MADRINAN O, LÓPEZ OL, KAUFER DI ET AL. Psychotic symptoms in Alzheimer's disease: evidence for subtypes. Am J Geriatric Psychiatry 2003; 11: 406-13.
22. SULTZER DL. Psychosis and antipsychotic medications in Alzheimer's disease, clinical management and research perspective. Dement Geriatr Cogn Disord 2004; 17: 78-90.
23. BOXER AL, KRAMER JH, DU AT, SCHUFF N, WEINER MW, MILLER BL ET AL. Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology 2003; 61: 1485-91.
24. DONOSO A, MANTEROLA J. La atrofia cortical posterior, una variante de la enfermedad de Alzheimer. Rev Neurol Arg 2001; 26: 176-80.
25. JOHNSON JK, HEAD E, KIM R, STARR A, COTMAN C. Clinical and pathological evidence for a frontal variant of Alzheimer's disease. Arch Neurol 1999;56: 1233-9.
26. OSAKI Y, BEN-SHLOMO Y, LEES AJ, DANIEL SE, COLOSIMO C, WENNING Q ET AL. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181-9.
27. BOEVE BF, MARAGANORE DM, PARISI JE, AHLSKOG JE, GRAFF-RADFORD N, CASELLI RJ ET AL. Pathological heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795-803.
28. TSCHAMPA HJ, NEUMANN M, ZERR I, HENKEL K, SCHRÖTER A, SCHULZ-SCHAEFFER W ET AL. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33-9.
29. MELANSON N, NALBANTOGLU J, BERKOVIC S, MELMED C, ANDERMAN E, ROBERTS LJ ET AL. Progressive myoclonus epilepsy in young adults with neuropathological features of Alzheimer' s disease. Neurology 1997; 49: 1732-3.
30. JELLINGER KA, MITTER-FERSTL E. The impact of cerebrovascular lesions in Alzheimer disease. J Neurol 2003; 250: 1050-5.
31. ROMAN GC. Vascular dementia changing the paradigm. Curr Opin Psychiatry 2003; 16: 635-41.
32. SIMONS M, KELLER P, DICHGANS J, SCHULZ J. Cholesterol and Alzheimer's disease: is there a link? Neurology 2001; 57: 1089-93.
33. REVESZ T, GHISO J, LASHLEY T, PLANT G, ROSTEGNO A, FRANGIONE B ET AL. Cerebral amyloid angiopathies: a pathological, biochemical and genetic view. J Neuropath Exp Neurol 2003; 62: 885-98.
34. GALVIN JE. Dementia with Lewy bodies. Arch Neurol 2003; 60: 1332-5.
35. MERDES AR, HANSEN LA, JESTE DV, GALASKO D, HOFSTETTER CR, HO GJ ET AL. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003; 60: 1586-90.
36. EMRE M. What causes mental dysfunction in Parkinson's disease? Mov Disord 2003; 18: S63-S71.
37. SCHUPF N, SERGIEVSKY GH. Genetic and host factors for dementia in Down' syndrome. Br J Psychiatry 2002; 180: 405-10.
38. MARGALLO-LANA M, MORRIS CM, GIBSON AM, TAN AL, KAY DW, TYRER SP ET AL. Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology 2004; 62: 1996-8.
39. SCHNEIDER JA, WATTS RL, GEORING M, BREWER RP, MIRRA SS. Corticobasal degeneration: neuropathological and clinical heterogeneity. Neurology 1997; 48: 959-69.
40. TSUCHIYA K, YAGISHITA S, IKEDA K, SANO M, TAKI K, HASHIMOTO K ET AL. Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD. Neuropathology 2004; 24: 46-55.